semaglutide treatments GLP-1 Treatment Specialist Semaglutide – SpringCare Clinic

If there are no adverse reactions and your body responds well, you may see an increase to 0.5 mg

However, the activity only becomes apparent once the degradation of DPP-4 has been prevented, as the majority of GLP-1 reaching the kidneys has already been processed by DPP-4

This degradation means your dose may deliver less active semaglutide than intended, potentially reducing appetite suppression and weight loss results

Souza CV et al

Repeatedly injecting in the same location can lead to lipohypertrophy, a condition characterized by lumpy, thickened areas of fatty tissue that can impair medication absorption and lead to unpredictable blood glucose levels